Builders Firstsource buy BiotechBee
Start price
03.09.23
/
70%
€138.35
Target price
30.11.25
€200.00
Performance (%)
-5.49%
End price
02.12.23
€130.75
Summary
This prediction ended on 02.12.23 with a price of €130.75. With a performance of -5.49%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Builders Firstsource | -16.832% | -16.832% |
iShares Core DAX® | 2.749% | 4.620% |
iShares Nasdaq 100 | 0.470% | -0.331% |
iShares Nikkei 225® | -2.930% | -5.556% |
iShares S&P 500 | 0.679% | 0.631% |
According to BiotechBee what are the pros and cons of Builders Firstsource for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Builders Firstsource diskutieren
Buy mit Kursziel 200,0
In the thread Trading Builders Firstsource
Buy beendet